In a randomized trial of patients with T2DM, ARBs were associated with significantly reduced urinary excretion of angiotensinogen in participants overall, and lower albuminuria in participants with high–normal albuminuria, compared with treatment with aliskiren, a direct renin inhibitor [53]. This evidence concerns the gene AGT and type 2 diabetes mellitus.